During the past decade, FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 15 clinical trials were completed, i.e. on average, 88.2% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" #1 sponsor was "Celgene" with 8 trials, followed by "Shire" with 3 trials sponsored, "Takeda" with 3 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" #1 collaborator was "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" are "Ulcerative Colitis" (9 trials), "Crohn Disease" (6 trials), "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (2 trials) and "Severe Hypertriglyceridemia" (2 trials). Many other conditions were trialed in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" in a lesser frequency.

Most popular intervention types in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" are "Drug" (22 trials) and "Other" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "GED-0301" (3 trials), "Ozanimod" (3 trials), "Adalimumab" (2 trials) and "CP-690,550" (2 trials). Other intervention names were less common.

The vast majority of trials in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS" are 22 trials for "All" genders.

Currently, there are NaN active trials in "FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in FSBI "Scientific Research Institute of Physyology and Basic Medicine" under the SB of RAMS, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".